3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Suspended
1
Recruiting
1
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
3
Gynecologic
2
Gastrointestinal
2
CNS
2
Thoracic
1
Other solid neoplasm
1
Lymphoid
1
Genitourinary
1
Dermatologic
1
Classical hematology
1
Breast
1
Conditions
Wilms Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Hepatic Veno-Occlusive Disease
1
Interventions
Cyclophosphamide
139
Rituximab
115
Etoposide
77
Vincristine
75
Doxorubicin
62
Cytarabine
61
Dexamethasone
58
Prednisone
55
fludarabine
52
Methotrexate
46
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
42
Lenalidomide
37
Gemcitabine
35
Radiotherapy
29
Melphalan
27
pegaspargase
22
Prednisolone
22
Ifosfamide
22
fludarabine phosphate
20
Busulfan
20
Cisplatin
19
Bendamustine Hydrochloride
19
Asparaginase
18
Peripheral Blood Stem Cell Transplantation
17
ibrutinib
16
Decitabine
16
Carmustine
16
Mercaptopurine
15
Filgrastim
15
Oxaliplatin
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Genetic Testing
×
Lymphoid
×
Clear all
NCT04168788
2019-11-19
MVO
University Hospital, Angers
Phase NA
Unknown
150 enrolled